A Study Regarding Tissue Response During and After Treatment for Anal Cancer
NCT ID: NCT05939401
Last Updated: 2025-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2023-12-01
2029-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The tumour microenvironment
* The localisation of and cellular interactions between the tumour and immune cells
* The gene and protein expression by cells present in the tumour and surrounding tissue.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
NCT04792892
Immunomonitoring and Biomarker Research in Patients With Squamous Cell Anal Carcinoma
NCT03942900
Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma
NCT05835960
Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma
NCT02849158
Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy
NCT05233540
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If it is not possible to take biopsies prior treatment blood samples will still be drawn.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biopsies
Biopsies and blood samples will be taken at time of diagnosis or recurrence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Göteborg University
OTHER
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva Angenete
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, , Sweden
Sahlgrenska University Hospital
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANCABio
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.